Get started
Innovation Pharmaceuticals Inc.Innovation Pharmaceuticals Inc.Innovation Pharmaceuticals Inc.

Innovation Pharmaceuticals Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

IPIX chart


Full chart

Key stats


Market capitalization
‪52.07 K‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income (FY)
‪−3.17 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪465.03 M‬
Beta (1Y)
−18.58

Employees


Employees (FY)
4
Change (1Y)
0
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−792.00 K‬ USD

About Innovation Pharmaceuticals Inc.


Sector
Health Technology
CEO
Leo Ehrlich
Headquarters
Wakefield
Website
ipharminc.com
Founded
2007
FIGI
BBG000BF2XQ0
Innovation Pharmaceuticals, Inc. is a clinical stage biotechnology company, which engages in the development of therapies with anti-infective, oncology, anti-inflammatory, and dermatology applications. It focuses on its antifungal drug candidate called Brilacidin. The company was founded by Krishna Kumar Menon, George W. Evans, and Leo Ehrlich on June 20, 2007 and is headquartered in Wakefield, MA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

IPIX news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of IPIX is 0.000200 USD — it has increased by 100.00% in the past 24 hours. Watch Innovation Pharmaceuticals Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Innovation Pharmaceuticals Inc. stocks are traded under the ticker IPIX.
IPIX stock hasn't changed in a week, the month change is a −93.33% fall, over the last year Innovation Pharmaceuticals Inc. has showed a −95.65% decrease.
IPIX reached its all-time high on Dec 12, 2014 with the price of 4.930000 USD, and its all-time low was 0.000001 USD and was reached on Jul 9, 2024. View more price dynamics on IPIX chart.
See other stocks reaching their highest and lowest prices.
IPIX stock is 100.00% volatile and has beta coefficient of −18.58. Track Innovation Pharmaceuticals Inc. stock price on the chart and check out the list of the most volatile stocks — is Innovation Pharmaceuticals Inc. there?
Yes, you can track Innovation Pharmaceuticals Inc. financials in yearly and quarterly reports right on TradingView.
No, IPIX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 4.00 employees. See our rating of the largest employees — is Innovation Pharmaceuticals Inc. on this list?
Like other stocks, IPIX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Innovation Pharmaceuticals Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Innovation Pharmaceuticals Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Innovation Pharmaceuticals Inc. stock shows the sell signal. See more of Innovation Pharmaceuticals Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.